Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma Multiforme
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 47 (1) , 59-63
- https://doi.org/10.1023/a:1006426215005
Abstract
Taxol has activity in the treatment of high grade gliomas but estramustine phosphate (EMP) has not been used in this setting. In vitrodata demonstrates that EMP is cytotoxic to glioma cell lines and...Keywords
This publication has 18 references indexed in Scilit:
- Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical TrialsJournal of Clinical Oncology, 1999
- New chemotherapy options for the treatment of malignant gliomasCurrent Opinion in Oncology, 1999
- Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors.Journal of Clinical Oncology, 1998
- Phase II study of paclitaxel in patients with recurrent malignant glioma.Journal of Clinical Oncology, 1996
- Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivoUrology, 1996
- Modulation of the Function of p-glycoprotein by EstramustineJNCI Journal of the National Cancer Institute, 1994
- Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and AstrocytesNeurosurgery, 1994
- Cytotoxicity of taxol in vitro against human and rat malignant brain tumorsCancer Chemotherapy and Pharmacology, 1994
- Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma CellsNeurosurgery, 1993
- Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.1992